India surgical robotics market was valued at USD 24.72 million in 2024 and is expected to reach USD 44.91 Million by 2030 with a CAGR of 10.42% during the forecast period. The India surgical robotics market is experiencing rapid expansion, driven by increasing demand for minimally invasive surgeries (MIS), technological advancements, and growing healthcare infrastructure investments. The rising prevalence of chronic diseases such as cancer, neurological disorders, and orthopedic conditions has further fueled the adoption of robotic-assisted procedures, particularly in orthopedics, urology, neurology, and gynecology. Leading hospitals, including Apollo, Fortis, and AIIMS, are actively integrating surgical robots to enhance precision, reduce post-operative complications, and improve patient outcomes. Medical tourism is a significant contributor, with India emerging as a preferred destination for cost-effective yet advanced robotic surgeries.
Despite the promising growth, the market faces several challenges, including high initial costs, a shortage of skilled robotic surgeons, and limited penetration in tier-2 and tier-3 cities. The cost of robotic surgical systems, such as Da Vinci (Intuitive Surgical) and Mako (Stryker), remains a significant barrier for mid-sized hospitals. Training requirements for surgeons and regulatory approvals slow down widespread adoption. However, government initiatives promoting “Make in India” and increased private-sector investments in robotic-assisted surgery centers are expected to bridge these gaps. As more domestic manufacturers and startups enter the market, the affordability and accessibility of surgical robotics are set to improve, making India a key player in the global landscape.
Key market drivers
Increasing healthcare infrastructure
India’s expanding healthcare infrastructure plays a crucial role in accelerating the adoption of surgical robotics, particularly in tertiary care hospitals and specialized medical centers. The government’s emphasis on strengthening public healthcare facilities and increasing private sector investments is creating a strong foundation for advanced surgical technologies. As of March 31, 2023, India had a well-established network of 1,69,615 Sub-Centres (SCs), 31,882 Primary Health Centres (PHCs), 6,359 Community Health Centres (CHCs), 1,340 Sub-Divisional/District Hospitals (SDHs), 714 District Hospitals (DHs), and 362 Medical Colleges (MCs), catering to both urban and rural populations. While these facilities are instrumental in delivering essential healthcare services, the growing burden of chronic diseases, rising surgical volumes, and the demand for minimally invasive procedures are pushing for increased adoption of robotic-assisted surgeries in well-equipped hospitals.
One of the key factors driving the expansion of robotic surgical procedures is the availability of skilled healthcare professionals. India currently has 2,39,911 Health Workers at SCs, 40,583 Doctors/Medical Officers at PHCs, 26,280 Specialists & Medical Officers at CHCs, and 45,027 Doctors and Specialists at SDHs and DHs. Additionally, the presence of 47,932 Staff Nurses at PHCs, 51,059 Nursing Staff at CHCs, and 1,35,793 Paramedical Staff at SDHs and DHs is enhancing the efficiency of surgical interventions, making hospitals more equipped to integrate robotic technologies. Moreover, with a total of 8,18,661 hospital beds available across PHCs, CHCs, SDHs, DHs, and medical colleges, the infrastructure is being upgraded to accommodate advanced surgical technologies, including robotic-assisted systems for orthopedics, urology, neurology, and gynecology.
The private healthcare sector is also playing a significant role in the rapid adoption of surgical robotics. Leading corporate hospitals such as Apollo, Fortis, Manipal, and Max Healthcare are investing in state-of-the-art robotic surgical systems to enhance precision and efficiency in complex procedures. With government initiatives like “Ayushman Bharat” and incentives for private investments in healthcare, the robotic surgery market in India is set for substantial growth, making cutting-edge surgical procedures more accessible to a wider population.
Growing prevalence of chronic diseases
The increasing burden of chronic diseases in India is a key factor fueling the demand for robotic-assisted surgeries, particularly in specialties like orthopedics, cardiology, urology, and oncology. With a rising aging population and shifting lifestyles, the prevalence of non-communicable diseases (NCDs) has surged, necessitating advanced surgical interventions for better patient outcomes. As per the Longitudinal Ageing Survey in India (LASI) (September 2024), 21% of India’s elderly population suffers from at least one chronic condition, with urban areas showing a higher prevalence (29%) compared to rural areas (17%). The most common chronic ailments include hypertension and diabetes, together accounting for 68% of all chronic diseases among the elderly. These conditions often lead to complications requiring surgical interventions, such as coronary artery bypass grafting (CABG), robotic-assisted knee and hip replacements, and minimally invasive robotic procedures for diabetic complications.
Furthermore, cardiovascular diseases (CVDs) affect 37% of individuals above 75 years, contributing to a significant portion of surgical procedures in India. The increasing number of heart-related surgeries, including robotic-assisted cardiac bypasses and valve repairs, is driving demand for precision-based robotic technology. Additionally, bone and joint diseases, such as osteoarthritis and rheumatoid arthritis, have led to a surge in robotic orthopedic surgeries, which provide superior outcomes compared to traditional methods. Chronic lung diseases are also a growing concern, often requiring thoracic surgeries, where robotic-assisted procedures offer enhanced accuracy with reduced complications.
Globally, chronic diseases are responsible for 74% of all deaths, with 77% occurring in low- and middle-income countries like India, according to the World Health Organization (WHO). This underscores the critical need for advanced surgical solutions, as the rising disease burden increases pressure on India’s healthcare system. The integration of robotic-assisted surgery enhances procedural success rates, reduces recovery times, and minimizes post-operative risks, making it a preferred choice for treating chronic disease-related conditions. As India continues to witness a rising number of NCD cases, the role of surgical robotics in ensuring high-precision, minimally invasive treatments will expand, strengthening its adoption across leading hospitals and specialty centers.
Key market challenges
High cost of surgical robotics
One of the biggest challenges in the India Surgical Robotics Market is the high cost associated with robotic surgical systems, maintenance, and procedural expenses. Advanced robotic platforms like Da Vinci (Intuitive Surgical), Mako (Stryker), and Rosa (Zimmer Biomet) require significant capital investment, often making them unaffordable for small and mid-sized hospitals, especially in tier-2 and tier-3 cities. The cost of a single robotic surgical system ranges between INR 10-20 crore ($1.2-$2.4 million), with additional expenses for training surgeons, software updates, and annual maintenance contracts (AMCs), further increasing the financial burden on healthcare providers.
Beyond the initial purchase, robotic-assisted surgeries are generally more expensive than conventional procedures due to the cost of consumables, robotic instruments, and extended operating times. For example, a robotic-assisted knee replacement may cost anywhere between INR 3-5 lakh ($3,600-$6,000) per procedure, nearly double the cost of traditional surgery. This pricing disparity limits accessibility for a large section of India’s population, particularly in rural and semi-urban areas where affordability remains a critical concern.
Additionally, insurance coverage for robotic surgeries is still limited, with many policies considering them an “elective procedure” rather than a necessity. This lack of financial support from insurers discourages patients from opting for robotic-assisted procedures, further restricting market penetration. While private hospitals in metro cities like Delhi, Mumbai, Bangalore, and Chennai are investing heavily in robotic surgery, government hospitals and mid-tier medical institutions struggle to justify the expenditure, given budget constraints and the need to cater to a larger patient base with cost-effective treatments.
Key market trends
Technological advancements in robotics
The India Surgical Robotics Market is witnessing rapid growth, largely driven by continuous technological advancements in robotic-assisted surgery. Innovations in artificial intelligence (AI), machine learning (ML), haptic feedback, miniaturization, and 5G connectivity are transforming robotic systems, making surgeries more precise, minimally invasive, and efficient. These advancements are reducing procedure time, improving patient outcomes, and expanding the scope of robotic-assisted surgeries beyond traditional applications like orthopedics and urology to include neurosurgery, gynecology, and general surgery.
One of the most significant advancements is the integration of AI and ML in surgical robotics, allowing systems to analyze vast amounts of surgical data, predict complications, and assist surgeons in decision-making. AI-powered real-time imaging and navigation technologies are enhancing precision in delicate procedures, such as brain and spinal surgeries, where millimeter-level accuracy is crucial. Additionally, haptic feedback and force-sensing technology are improving surgeons’ ability to perform complex operations with enhanced control, reducing the risk of human error.
The development of next-generation robotic systems with smaller, more flexible robotic arms is another notable trend. Single-port robotic surgery, where the entire surgical procedure is performed through a single incision, is gaining popularity, minimizing trauma and shortening recovery times. Companies like Medtronic, CMR Surgical, and Johnson & Johnson (Verb Surgical) are investing in compact, cost-effective robotic systems to make robotic surgery more accessible in India’s mid-tier and government hospitals.
Another game-changer is the integration of 5G connectivity and remote surgery capabilities. With ultra-low latency, telerobotic surgery allows expert surgeons from metro cities to operate on patients in remote locations, addressing India’s disparity in specialized healthcare access. This is particularly relevant for rural areas, where access to highly skilled surgeons is limited.
Segmental insights
End use insights
Based on End Use, Inpatient have emerged as the dominating segment in the India Surgical Robotics Market in 2024. This is primarily due to the complex nature of robotic-assisted surgeries, the need for post-operative monitoring, and the high cost associated with these procedures. Most robotic surgeries, such as orthopedic joint replacements, urological procedures (prostatectomies), gynecological surgeries (hysterectomies), and neurosurgeries, are performed in multispecialty hospitals and tertiary care centers, where patients require longer recovery periods and specialized post-operative care.
Additionally, the high infrastructure requirements for robotic-assisted surgeries, including dedicated surgical suites, trained personnel, and advanced robotic systems, make inpatient hospitals the primary adopters. Leading hospitals in metro cities, such as Apollo Hospitals, AIIMS, Max Healthcare, and Fortis Healthcare, have heavily invested in surgical robotics, reinforcing the inpatient segment’s dominance.
Regional insights
Based on Region, South India have emerged as the dominating region in the India Surgical Robotics Market in 2024. It is driven by its well-established healthcare infrastructure, high concentration of multispecialty hospitals, and faster adoption of advanced medical technologies. Cities such as Chennai, Bengaluru, Hyderabad, and Kochi have become key hubs for robotic-assisted surgeries, with hospitals investing heavily in state-of-the-art robotic surgical systems to enhance precision and patient outcomes.
Tamil Nadu and Karnataka lead in the adoption of surgical robotics, with premier hospitals like Apollo Hospitals, Narayana Health, Manipal Hospitals, and Fortis Healthcare pioneering the use of robotic-assisted procedures in orthopedics, urology, gynecology, and neurology. Bengaluru, often referred to as the “Silicon Valley of India,” has also seen a rise in medical technology startups and research initiatives focused on robotic surgery, further fueling regional growth.
Additionally, South India’s strong medical tourism sector plays a crucial role in market dominance. Cities like Chennai and Hyderabad attract a large number of international and domestic patients seeking robotic-assisted surgeries for knee replacements, prostate cancer, and minimally invasive procedures. The presence of renowned medical institutions and government support for advanced healthcare technologies has further solidified South India’s position as the top-performing region in India’s surgical robotics market. TechSci Research